Clinical Trial Update: Theophylline Treatment for Pseudohypoparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing theophylline for pseudohypoparathyroidism and Albright hereditary osteodystrophy; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albright Hereditary Osteodystrophy
• Pseudohypoparathyroidism

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING